# OnCo record hcw11-018b (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/hcw11-018b/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "hcw11-018b" ;
  schema:name "HCW11-018b"@en ;
  schema:description "HCW11-018b is an experimental injection under the skin designed to direct the body's T cells against solid tumours. HCW Biologics plans to ask the US regulator in 2027 for permission to begin its first trial in people."@en ;
  schema:url <https://onco.cc/drugs/hcw11-018b/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1828673/000149315226045532/forms-1.htm> ;
  onco:status "preclinical" ;
  onco:tag "pipeline" ;
  onco:modality "Tetravalent T-cell engager (fusion protein, subcutaneous)" ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/> ;
  onco:companies <https://onco.cc/companies/hcw-biologics/> .